The Centers for Disease Control and Prevention (CDC) has updated its influenza statistics for the 2012-2013 influenza season for Week 1 ending Jan. 5, 2013. Public health officials are reporting that from Dec. 30, 2012 through Jan. 5, 2013, influenza activity remained elevated in the U.S., but may be decreasing in some areas.
The Centers for Disease Control and Prevention (CDC) has updated its influenza statistics for the 2012-2013 influenza season for Week 1 ending Jan. 5, 2013. Public health officials are reporting that from Dec. 30, 2012 through Jan. 5, 2013, influenza activity remained elevated in the U.S., but may be decreasing in some areas. Here are the details:
-Viral Surveillance: Of 12,876 specimens tested and reported by U.S. World Health Organization (WHO) and National Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories, 4,222 (32.8 percent) were positive for influenza.
- Pneumonia and Influenza Mortality: The proportion of deaths attributed to pneumonia and influenza (P&I) was slightly above the epidemic threshold.
- Influenza-Associated Pediatric Deaths: Two influenza-associated pediatric deaths were reported. One was associated with an influenza A (H3) virus and one was associated with an influenza A virus for which the subtype was not determined.
- Outpatient Illness Surveillance: The proportion of outpatient visits for influenza-like illness (ILI) was 4.3 percent; above the national baseline of 2.2 percent. Nine of 10 regions reported ILI above region-specific baseline levels. Twenty-four states and New York City experienced high ILI activity; 16 states experienced moderate ILI activity; five states experienced low ILI activity; five states experienced minimal ILI activity, and the District of Columbia had insufficient data.
- Geographic Spread of Influenza: Forty-seven states reported widespread geographic influenza activity; two states reported regional activity; the District of Columbia reported local activity; one state reported sporadic activity; Guam reported no influenza activity, and Puerto Rico and the U.S. Virgin Islands did not report.
Implementing FDA 21 CFR Part 820 & ISO 13485 on Quality System Regulation
August 30th 2024The FDA's 21 CFR Part 820 and ISO 13485 are crucial in regulating medical device quality systems. Harmonizing these standards by 2026 will streamline compliance, improve patient access to devices, and align US regulations with global practices.
The Long-Term Care Chronicles: The Great Mitigators
August 27th 2024Enjoy this first installment of The Long-Term Care Chronicles With Robbie Hilliard, MSN, RN CIC, a column about managing special infection control situations in the long-term care patient population. This installment is about when 2 experts conflict about best care.
Urgent Need for a Paradigm Shift in Infectious Disease Control Amid 2024 Outbreaks
August 26th 2024The 2024 surge in infectious diseases like mpox, measles, and meningitis demands a paradigm shift in control strategies, emphasizing expanded expertise, improved airborne precautions, and rethinking cost-effectiveness in healthcare to prevent future outbreaks and protect public health.
Navigating Infection Prevention Challenges Amid 2024 Outbreaks: Strategies for Success
August 22nd 2024As infectious diseases resurge in 2024, this article explores how IPs can manage outbreaks, allocate resources, use technology for surveillance, and collaborate with senior leaders to ensure business continuity and patient safety in health care settings.